Back to top
more

Avanos Medical (AVNS)

(Delayed Data from NYSE)

$22.80 USD

22.80
162,522

+0.15 (0.66%)

Updated Oct 15, 2024 04:00 PM ET

After-Market: $22.81 +0.01 (0.04%) 6:46 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

1-Strong Buy of 5 1        

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value D Growth C Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 33% (82 out of 250)

Industry: Medical - Instruments

Better trading starts here.

Zacks News

Why Is Avanos Medical (AVNS) Up 5.7% Since Last Earnings Report?

Avanos Medical (AVNS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Avanos Medical (AVNS) Q2 Earnings and Revenues Top Estimates

Avanos Medical's (AVNS) second-quarter results benefit from contribution from Chronic Care segment.

Avanos Medical (AVNS) Q2 Earnings and Revenues Surpass Estimates

Avanos Medical (AVNS) delivered earnings and revenue surprises of 262.50% and 10.19%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

Avanos Medical (AVNS) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release

Avanos Medical (AVNS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Here's Why You Should Retain Avanos Medical Stock for Now

Investor confidence is high on Avanos Medical (AVNS), thanks to solid prospects.

Avanos Medical (AVNS) Up 0.1% Since Last Earnings Report: Can It Continue?

Avanos Medical (AVNS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Here's Why You Should Retain Avanos Medical Stock for Now

Avanos Medical (AVNS) continues to benefit from strong performing segments and robust product portfolio. However, stiff competition remains a concern.

Avanos Medical (AVNS) Q1 Earnings Lag Estimates, Revenues Top

Avanos Medical's (AVNS) first-quarter results benefit from segmental contribution.

Avanos Medical (AVNS) Lags Q1 Earnings Estimates

Avanos Medical (AVNS) delivered earnings and revenue surprises of -5.88% and 4.04%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

Avanos Medical (AVNS) Earnings Expected to Grow: Should You Buy?

Avanos Medical (AVNS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Here's Why You Should Hold on to Avanos Medical Stock Now

Avanos Medical (AVNS) continues to benefit from strong performing segments and robust product portfolio. However, weak performance at Acute Pain unit raises concern.

Why Is Avanos Medical (AVNS) Down 30.2% Since Last Earnings Report?

Avanos Medical (AVNS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Here's Why You Should Hold Avanos Medical (AVNS) Stock Now

Avanos (AVNS) gains from solid fourth-quarter show despite headwinds in the Acute Pain business.

Avanos (AVNS) Earnings and Revenues Beat Estimates in Q4

Avanos (AVNS) gains from segmental contributions in Q4.

Avanos Medical (AVNS) Beats Q4 Earnings and Revenue Estimates

Avanos Medical (AVNS) delivered earnings and revenue surprises of 6.25% and 6.73%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?

New Strong Sell Stocks for January 14th

Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today

New Strong Sell Stocks for January 8th

Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today

Why Is Avanos Medical (AVNS) Down 1.8% Since Last Earnings Report?

Avanos Medical (AVNS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Avanos (AVNS) Earnings and Revenues Miss Estimates in Q3

Avanos (AVNS) third-quarter results benefit from higher revenues and strong segmental performance.

Avanos Medical (AVNS) Q3 Earnings and Revenues Lag Estimates

Avanos Medical (AVNS) delivered earnings and revenue surprises of -6.25% and -5.11%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

Earnings Preview: Avanos Medical (AVNS) Q3 Earnings Expected to Decline

Avanos Medical (AVNS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Avanos Medical (AVNS) Catches Eye: Stock Jumps 6.2%

Avanos Medical (AVNS) saw a big move last session, as its shares jumped more than 6% on the day, amid huge volumes.

AngioDynamics Boosts VIT Product Portfolio With New Buyout

AngioDynamics (ANGO) is likely to see an expansion of its already existing VIT product portfolio with the buyout of Eximo Medical.

Avanos Medical (AVNS) Down 8.9% Since Last Earnings Report: Can It Rebound?

Avanos Medical (AVNS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

New Strong Sell Stocks for August 19th

Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today